FDA Drug recall D-0171-2017
Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 Mcg, 50 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 1…
- FDA Drug
- Class III
- terminated
- Published 2016-12-14
On 2016-12-14 the FDA classified a Class III recall of Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 Mcg, 50 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 1… by Teva Pharmaceuticals Usa, citing failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0171-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-11-01 |
| Published | 2016-12-14 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | US |
Product
Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 Mcg, 50 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-210-13.
Reason
Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.
Identifiers
| code_info | Lot #: 150335, 150336, Exp. 4/2017 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0171-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.